Bio-Techne share price logo

Bio-Techne

NASDAQ: TECH

Large Cap

$72.80

-0.04

(-0.05%)

as on

Bio-Techne Stock Performance

as on November 14, 2026 at 2:16 pm IST

  • Day's Low

    Day's High

    $72.73
    $72.85
    downward going graph

    0.10%

    Downside

    0.07%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $43.20
    $72.88
    downward going graph

    40.67%

    Downside

    0.11%

    Upside

    downward going graph

Bio-Techne share price movements today

Previous Close
$72.84
Open
$72.85
Volume
1.5M
Market Cap
$11.4B
Dividend Yield
0.44%
Day's Low - High
$72.73 - $72.85
52 Week Low - High
$43.20 - $72.88

Bio-Techne Historical Returns

1 Month Return
+ 0.41 %
3 Month Return
+ 0.55 %
1 Year Return
+ 22.6 %
3 Year Return
+ 20.61 %
5 Year Return
-42.28 %

Bio-Techne Stock Fundamentals & Key Indicators

Check Bio-Techne market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$11.4B

EPS (TTM)

1.1

Dividend Yield

0.44%

Quarterly Earnings Growth YOY

-0.25%

PE Ratio (TTM)

66.23

Industry PE ratio

7.76

PEG Ratio

0.55

EBITDA

328.8M

Revenue (TTM)

1.2B

Profit Margin

65.75%

Return On Equity TTM

8.22%

Bio-Techne vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Bio-Techne with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Sell$11.4B-42.28%66.2365.75%0.44%
Neutral$100.6B0.07%-35.1828.00%0.00%
StrongBuy$47.5BNA68.7388.39%0.00%
StrongBuy$137.6B187.58%34.7885.57%0.00%
Buy$99.2B51.37%20.2985.77%0.39%

Stock Returns calculator for Bio-Techne Stock including INR - Dollar returns

The Bio-Techne stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Bio-Techne investment value today

Current value as on today

₹1,30,352

Returns

₹30,352

(+30.35%)

Returns from Bio-Techne Stock

₹22,600 (+22.6%)

Dollar Impact

₹7,751 (+7.75%)

Analyst Recommendation on Bio-Techne Stock

Based on 2 analysts

SELL

0.00%

Buy

50.00%

Hold

50.00%

Sell

Based on 2 analysts, 50% of analysts recommend a 'SELL' rating for Bio-Techne. Average target price of $70.5

Bio-Techne Share Price Target

Get share price movements and forecasts by analysts on Bio-Techne.

What analysts predicted

-3.26%DOWNSIDE

Target Price

$70.5

Current Price

$72.8

Analyzed by

2 Analysts

High

$73

Target

$70.50

Low

$73

Bio-Techne target price $70.5, a slight downside of -3.26% compared to current price of $72.8. According to 2 analysts rating.

Indian Investors' Interest in Bio-Techne Stock

Search interest for Bio-Techne Stock has increased by 10% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:10% versus previous 30 day period

Bio-Techne Quarterly Profit & Loss

All numbers in Millions USD

Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Total Revenue
306
289
297
316
316
286
295
311
321
299
Gross Profit
203
183
193
214
198
188
191
208
211
196
Operating Income
45
39
47
38
-23
47
54
75
74
36
EBITDA
72
70
72
67
6
75
77
98
91
60
Interest Expense
2
2
2
2
2
2
2
3
-2
2
Depreciation
28
28
27
27
27
24
24
24
24
23
Income Before Tax
41
40
42
38
-22
47
50
71
70
34
Income Tax Expense
1
6
7
15
-5
9
12
20
16
6
Net Income
40
33
34
22
-17
38
38
51
54
28
Net Profit Margin
66.43%
63.23%
65.27%
67.86%
62.72%
65.65%
64.65%
66.88%
65.82%
65.60%

Bio-Techne Annual Profit & Loss

All numbers in Millions USD

Jun 2017
Jun 2018
Jun 2019
Jun 2020
Jun 2021
Jun 2022
Jun 2023
Jun 2024
Jun 2025
Jun 2026
Total Revenue
563
642
714
738
931
1,105
1,136
1,159
1,219
1,215
Gross Profit
374
432
473
483
632
756
769
769
790
799
Operating Income
121
136
125
157
237
296
298
206
102
251
EBITDA
179
200
211
378
249
413
457
313
216
343
Interest Expense
7
10
21
19
13
11
11
15
8
5
Depreciation
60
64
78
82
87
101
107
111
109
97
Income Before Tax
113
125
112
276
148
301
338
185
98
240
Income Tax Expense
35
0
15
47
8
38
53
17
25
58
Net Income
77
125
96
229
140
272
285
168
73
181
Net Profit Margin
66.53%
67.21%
66.31%
65.41%
67.97%
68.42%
67.72%
66.41%
64.80%
65.77%

Bio-Techne Quarterly Cash Flow

All numbers in Millions USD

Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Net Income
40
33
34
22
-17
38
38
51
54
28
Operating Cash Flow
75
63
84
41
98
27
82
86
95
73
Investing Cash Flow
-8
-21
-5
-8
0
0
-5
-5
-7
-3
Financing Cash Flow
-60
-11
-83
-68
-90
-44
-48
-42
-33
16
Change in Cash
11
35
-9
-36
21
-17
27
36
54
85

Bio-Techne Annual Cash Flow

All numbers in Millions USD

Jun 2017
Jun 2018
Jun 2019
Jun 2020
Jun 2021
Jun 2022
Jun 2023
Jun 2024
Jun 2025
Jun 2026
Net Income
76
126
96
229
139
263
285
168
73
181
Operating Cash Flow
143
170
181
205
352
325
254
298
287
292
Investing Cash Flow
-305
-38
-336
27
-243
-96
-265
-203
-35
-18
Financing Cash Flow
189
-99
134
-183
-62
-242
22
-122
-253
-169
Change in Cash
27
30
-21
45
52
-26
8
-28
10
102

Global Institutional Holdings in Bio-Techne

Check out the Institutions with significant holdings in Bio-Techne.

Funds
Holdings
Vanguard
10.08%
VANGUARD INDEX FUNDS
9.35%
BlackRock, Inc.
8.93%
iShares
5.16%
David Costen Haley
4.34%

Bio-Techne News & Key Events

  • img

    Today's Timeline - 26 August

    Wed, 11:43 AM

    -

    Bio-Techne faces restrictive merger terms and a hefty termination fee, impacting competitive bidding and future deal leverage.

    Wed, 03:25 PM

    -

    Bio-Techne's organic revenue underperformance suggests a need for acquisitions to stimulate growth amid shrinking returns on capital.

Insights on Bio-Techne

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 6 months, TECH stock has moved up by 68.1%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Moderna, Inc. Common Stock has given 191.8% return, outperforming this stock by 172.3%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 801.8% return, outperforming this stock by 779.2%

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 321.19M → 299.71M (in $), with an average decrease of 6.7% per quarter

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, 54.61M → 28.29M (in $), with an average decrease of 48.2% per quarter

About Bio-Techne

Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Spatial Biology. The Protein Sciences segment develops and manufactures biological reagents used in various aspects of life science research, diagnostics, and cell and gene therapy, such as cytokines and growth factors, antibodies, small molecules, tissue culture sera, and cell selection technologies. This segment also offers proteomic analytical tools for automated western blot and multiplexed ELISA workflow consists of manual and automated protein analysis instruments and immunoassays for use in quantifying proteins in various biological fluids. The Diagnostics and Genomics segment develops and manufactures diagnostic products, including controls, calibrators, and diagnostic assays for regulated diagnostics market, exosome-based molecular diagnostic assays, advanced tissue-based in-situ hybridization assays for spatial genomic and tissue biopsy analysis, and genetic and oncology kits for research and clinical applications; and sells products for genetic carrier screening, oncology diagnostics, molecular controls, and research, as well as instruments and process control products for hematology, blood chemistry and gases, and coagulation controls and reagents used in various diagnostic applications. The company was formerly known as Techne Corporation and changed its name to Bio-Techne Corporation in November 2014. Bio-Techne Corporation was incorporated in 1976 and is headquartered in Minneapolis, Minnesota.
OrganisationBio-Techne
Headquarters614 McKinley Place N.E., Minneapolis, MN, 55413, US
IndustryBiotechnology
CEOKim Kelderman

Key Management of Bio-Techne

Name

Title

Mr. James T. Hippel CPA

Executive VP of Finance & CFO

Mr. Luca Cicchetti

Managing Director

Ms. Cheryl Bethune

Senior VP & Chief Human Resources Officer

Mr. Kim Kelderman

CEO, President & Director

Mr. Shane V. Bohnen

Senior VP, General Counsel, Corporate Secretary & Chief Sustainability Officer

Mr. William A. Geist

President of Protein Sciences Segment

Mr. Steven C. Crouse

President of Diagnostics & Spatial Biology Segment

Dr. Gary J. Latham Ph.D.

VP & CTO

Mr. David Clair C.F.A.

Vice President of Investor Relations

Mr. Martin Wirtz

Senior Vice President of Strategy & Corporate Development

FAQs

What is Bio-Techne share price today?

Bio-Techne share price today is $72.80 as on at the close of the market. Bio-Techne share today touched a day high of $72.85 and a low of $72.73.

What is the 52 week high and 52 week low for Bio-Techne share?

Bio-Techne share touched a 52 week high of $72.88 on and a 52 week low of $43.20 on . Bio-Techne stock price today i.e. is closed at $72.80,which is 0.11% down from its 52 week high and 68.54% up from its 52 week low.

What is Bio-Techne's market capitalisation today?

Bio-Techne market capitalisation is $0.01T as on .

How to invest in Bio-Techne Stock (TECH) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Bio-Techne on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Bio-Techne Stock (TECH) from India?

Indian investors can start investing in Bio-Techne (TECH) shares with as little as ₹94.23999786376953 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹942.40 in Bio-Techne stock (as per the Rupee-Dollar exchange rate as on ). Based on Bio-Techne share’s latest price of $72.80 as on November 14, 2026 at 8:46 am IST, you will get 0.1374 shares of Bio-Techne. Learn more about fractional shares .

What are the returns that Bio-Techne has given to Indian investors in the last 5 years?

Bio-Techne stock has given -42.28% share price returns and 26.4% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?